News summary

[Jinhe Biotech: Domestic prices of chlortetracycline products and vaccine products have large price increases expectations and room] Securities Times e Company News, Jinhe Biotech recently stated in a roadshow that in terms of domestic business, with the downstream pig breeding business The situation has improved, the prosperity has improved, and the company's domestic90freespinsnodeposit...

Newsletter text

[Jinhe Biotech: Domestic prices of chlortetracycline products and vaccine products have large expectations and room for price increases] Securities Times e Company News, Jinhe Biotech recently stated in a roadshow that in terms of domestic business, as the downstream pig breeding business The situation improves and the prosperity improves, the company's domestic prices of chlortetracycline products and vaccine products will also undergo certain adjustments, with greater expectations and room for price increases. In 2023, American companies will achieve90freespinsnodepositWith the best performance in history, chlortetracycline for cattle in the U.S. market will be used in large quantities since 2023. Sales of chlortetracycline hydrochloride drinking water agent products are also relatively strong. Currently, only Jinhe sells it in the United States, achieving a good growth rate. The company is the world's largest producer of chlortetracycline and has strong pricing power.